Calidi Biotherapeutics CLDI
NYSE CLDI
$0.64 0.00 (-0.75%)
As of: Oct 23, 2026 · 2:46 PM EDT

Calidi Biotherapeutics (CLDI) Net Shares Issued and Repurchased (2022 - 2025)

Updated

Analysis

Calidi Biotherapeutics (CLDI) Net Shares Issued and Repurchased (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,127.89 Bn 1,096.47 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.11 Bn 554.97 Bn 17.30 Bn -966.00 Mn
3 AbbVie 504.69 Bn 477.80 Bn 12.70 Bn -9.00 Mn
4 Merck 358.24 Bn 312.62 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 290.13 Bn 254.12 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.87 Bn 193.27 Bn 7.24 Bn -
8 Gilead Sciences 194.91 Bn 169.11 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn -
10 Calidi Biotherapeutics 913,319.97 -24.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.27 Mn
Sep 30, 2025 -2.78 Mn
Jun 30, 2025 2.78 Mn
Mar 31, 2025 3.50 Mn
Dec 31, 2024 5.09 Mn
Sep 30, 2024 2.74 Mn
Sep 30, 2023 2.81 Mn
Jun 30, 2023 50,000.00
Mar 31, 2023 181,000.00
Sep 30, 2022 114,000.00
API Access

Calidi Biotherapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=CLDI&period=max&api_key=YOUR_API_KEY